Pablo Micó Martínez

Dr. Pablo Micó Martínez


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
PMPablo Micó Martínez
Pablo Micó Martínez
JGJosé LUIS García-Gimenez
José LUIS García-Gimenez
Marta Seco-CerveraMarta Seco-Cervera
Marta Seco-Cervera
ALA Lopez-Roldan
A Lopez-Roldan
PAPj Alminana-Pastor
Pj Alminana-Pastor
FPFv Pallardo
Fv Pallardo
Background: The study and identification of new biomarkers for periodontal disease, such as microRNAs (miR-NAs), may give us more information about the location and severity of the disease and will serve as a basis for treatment planning and disease-monitoring. miRNAs are a group of small RNAs which are involved in gene regulation by binding to their messenger RNA target (mRNA). In this pilot study, the procedure for purifying miRNAs from gingival crevicular fluid (GCF) was, for the first time, described. In addition, the concentration of miRNAs in GCF was analyzed and compared between patients with moderate or severe chronic periodontitis (CP) and healthy controls. Material and Methods: GCF samples were collected from single-rooted teeth of patients with moderate or severe CP (n=9) and of healthy individuals (n=9). miRNAs were isolated from GCF using miRNeasy Serum/Plasma kit (Qiagen, CA. USA). Reverse transcription polymerase chain reaction (qRT-PCR) was used to determine the ex-pression of a series of miRNAs candidates that are related to bone metabolism. The significance of differences in miRNA levels between both groups was determined using Mann-Whitney U test. Results: The results from this pilot study indicate that miRNAs can be isolated from GCF. Six different miRNAs were analyzed (miR-671, miR-122, miR-1306, miR-27a, miR-223, miR-1226), but only miR-1226 showed statically significant differences between the CP group and healthy controls (p<0.05). This miRNA was downregulated in patients with CP. Conclusions: Within the limitations of the present study, it may be concluded that miR-1226 can be a promising bio-marker for periodontal disease, adding relevant information to common clinical parameters used for diagnosis and prognosis of periodontitis.

1 January 2021 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
PMPablo Micó Martínez
Pablo Micó Martínez
PAPedro Almiñana-Pastor
Pedro Almiñana-Pastor
FAFrancisco Alpiste-Illueca
Francisco Alpiste-Illueca
ARAndrés López Roldán
Andrés López Roldán
Micó-Martínez P, et al. J Periodontal Implant Sci. 2021 Jun;51:e25. https://doi.org/10.5051/jpis.2007540377

18 November 2023 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
PAPedro Almiñana-Pastor
Pedro Almiñana-Pastor
FAFrancisco M. Alpiste-Illueca
Francisco M. Alpiste-Illueca
PMPablo Micó Martínez
Pablo Micó Martínez
JGJosé LUIS García-Gimenez
José LUIS García-Gimenez
EGEva García-Lopez
Eva García-Lopez
ALAndrés López-Roldán
Andrés López-Roldán
Objectives: microRNAs (miRNAs) present in the gingival crevicular fluid (GCF) of patients with chronic periodontitis may serve as biomarkers of periodontal disease. The aim of this study was to perform a miRNA-sequencing study of all miRNAs present in GCF, comparing miRNA expression level profiles between advanced chronic periodontitis (CP) patients and healthy subjects (HS). Materials and methods: GCF samples were collected from the single-rooted teeth of patients with severe CP (n = 11) and of HS (n = 12). miRNAs were isolated from GCF using an miRNeasy Serum/Plasma kit(Qiagen GmbH, Hilden, Germany). Reverse transcription polymerase chain reaction (qRT-PCR) was used to determine the expression levels of miRNA candidates involved in periodontal pathogenesis. Results: Of all the sequenced miRNAs, miR-199, miR-146a, miR-30a, and miR-338 were identified as best representing the CP patient samples. The validation study identified miR-199 as the most powerful biomarker used to define periodontitis. Conclusions: Upon sequencing all known miRNAs in GCF for the first time, we uncovered several potential biomarkers to define periodontitis. Identifying miRNAS in the GCF using high-throughput approaches will clarify the role of these molecules in periodontitis and provide biomarkers with potential applications.